InvestorsHub Logo
Followers 62
Posts 7549
Boards Moderated 1
Alias Born 01/02/2003

Re: Laurent Maldague post# 406863

Wednesday, 04/05/2023 4:29:18 PM

Wednesday, April 05, 2023 4:29:18 PM

Post# of 425923
if the Mitigate trial were extended or stopped for futility, we would have heard about it by now...IMO the trial has had some success and the results are now being complied and readied for presentation at a conference...The fact that KIWI is still being prescribed Vascepa by Kaiser is a plus...since Kaiser is not known for wasting money.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News